was read the article
array:21 [ "pii" => "X201325141105158X" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2010.Nov.10729" "estado" => "S300" "fechaPublicacion" => "2011-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:221-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4361 "formatos" => array:3 [ "EPUB" => 318 "HTML" => 3498 "PDF" => 545 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699511051582" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2010.Nov.10729" "estado" => "S300" "fechaPublicacion" => "2011-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2011;31:221-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7071 "formatos" => array:3 [ "EPUB" => 318 "HTML" => 6109 "PDF" => 644 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Nefropatía tras la administración de inhibidores de la angiogénesis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "221" "paginaFinal" => "222" ] ] "contieneResumen" => array:1 [ "es" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "ARANTXA VELLO ROMÁN, A. Vello Román, MIRIAM SAMPRÓN RODRÍGUEZ, M. Samprón Rodríguez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo" "autores" => array:10 [ 0 => array:2 [ "nombre" => "ARANTXA" "apellidos" => "VELLO ROMÁN" ] 1 => array:2 [ "Iniciales" => "A." "apellidos" => "Vello Román" ] 2 => array:2 [ "nombre" => "MIRIAM" "apellidos" => "SAMPRÓN RODRÍGUEZ" ] 3 => array:2 [ "Iniciales" => "M." "apellidos" => "Samprón Rodríguez" ] 4 => array:2 [ "nombre" => "BEATRIZ" "apellidos" => "PAZOS ARIAS" ] 5 => array:2 [ "Iniciales" => "B." "apellidos" => "Pazos Arias" ] 6 => array:2 [ "nombre" => "CARLOS" "apellidos" => "ROMERO REINOSO" ] 7 => array:2 [ "Iniciales" => "C." "apellidos" => "Romero Reinoso" ] 8 => array:2 [ "nombre" => "ANGELES" "apellidos" => "PETEIRO CANCELO" ] 9 => array:2 [ "Iniciales" => "A." "apellidos" => "Peteiro Cancelo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X201325141105158X" "doi" => "10.3265/Nefrologia.pre2010.Nov.10729" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051582?idApp=UINPBA000064" "url" => "/02116995/0000003100000002/v0_201502091417/X0211699511051582/v0_201502091417/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251411051571" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2010.Nov.10508" "estado" => "S300" "fechaPublicacion" => "2011-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:223-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8435 "formatos" => array:3 [ "EPUB" => 314 "HTML" => 7465 "PDF" => 656 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "First case of peritoneal infection due to Oerskovia turbata (Cellulosimicrobium funkei)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "223" "paginaFinal" => "225" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Primer caso de infección peritoneal por Oerskovia turbata (Cellulosimicrobium funkei)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10508_108_15826_en_10508_1.jpg" "Alto" => 399 "Ancho" => 600 "Tamanyo" => 191528 ] ] "descripcion" => array:1 [ "en" => "Oerskovia culture on a blood agar plate" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. BETANCOURT CASTELLANOS, E. PONZ CLEMENTE, D. FONTANALS AYMERICH, C. BLASCO CABAÑAS, D. MARQUINA PARRA, C. GRAU PUEYO, M. GARCÍA GARCÍA" "autores" => array:8 [ 0 => array:2 [ "Iniciales" => "L." "apellidos" => "BETANCOURT CASTELLANOS" ] 1 => array:2 [ "Iniciales" => "L." "apellidos" => "BETANCOURT CASTELLANOS" ] 2 => array:2 [ "Iniciales" => "E." "apellidos" => "PONZ CLEMENTE" ] 3 => array:2 [ "Iniciales" => "D." "apellidos" => "FONTANALS AYMERICH" ] 4 => array:2 [ "Iniciales" => "C." "apellidos" => "BLASCO CABAÑAS" ] 5 => array:2 [ "Iniciales" => "D." "apellidos" => "MARQUINA PARRA" ] 6 => array:2 [ "Iniciales" => "C." "apellidos" => "GRAU PUEYO" ] 7 => array:2 [ "Iniciales" => "M." "apellidos" => "GARCÍA GARCÍA" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511051574" "doi" => "10.3265/Nefrologia.pre2010.Nov.10508" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051574?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051571?idApp=UINPBA000064" "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051571/v0_201502091641/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251411051598" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2010.Dec.10741" "estado" => "S300" "fechaPublicacion" => "2011-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:219-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5118 "formatos" => array:3 [ "EPUB" => 298 "HTML" => 4086 "PDF" => 734 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Successful pregnancy in a patient with chronic renal failure undergoing haemodialysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "219" "paginaFinal" => "221" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Gestación con éxito en una paciente con insuficiencia renal crónica en programa de hemodiálisis" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10741_108_15824_en_t2_carta.jpg" "Alto" => 349 "Ancho" => 600 "Tamanyo" => 155686 ] ] "descripcion" => array:1 [ "en" => "Clinical and laboratory variables and drug dose during pregnancy" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "K.R. Furaz Czerpak, A. Puente García, E. Corchete Prats, M.A. Moreno, R. Martín Hernandez" "autores" => array:5 [ 0 => array:2 [ "Iniciales" => "K.R." "apellidos" => "Furaz Czerpak" ] 1 => array:2 [ "Iniciales" => "A." "apellidos" => "Puente García" ] 2 => array:2 [ "Iniciales" => "E." "apellidos" => "Corchete Prats" ] 3 => array:2 [ "Iniciales" => "M.A." "apellidos" => "Moreno" ] 4 => array:2 [ "Iniciales" => "R." "apellidos" => "Martín Hernandez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511051590" "doi" => "10.3265/Nefrologia.pre2010.Dec.10741" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511051590?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411051598?idApp=UINPBA000064" "url" => "/20132514/0000003100000002/v0_201502091641/X2013251411051598/v0_201502091641/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Nephropathy following administration of angiogenesis inhibitors" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "221" "paginaFinal" => "222" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "ARANTXA VELLO ROMÁN, A. Vello Román, MIRIAM SAMPRÓN RODRÍGUEZ, M. Samprón Rodríguez, BEATRIZ PAZOS ARIAS, B. Pazos Arias, CARLOS ROMERO REINOSO, C. Romero Reinoso, ANGELES PETEIRO CANCELO, A. Peteiro Cancelo" "autores" => array:10 [ 0 => array:4 [ "nombre" => "ARANTXA" "apellidos" => "VELLO ROMÁN" "email" => array:1 [ 0 => "arantxavr6@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:4 [ "Iniciales" => "A." "apellidos" => "Vello Román" "email" => array:1 [ 0 => "arantxavr6@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "MIRIAM" "apellidos" => "SAMPRÓN RODRÍGUEZ" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "Iniciales" => "M." "apellidos" => "Samprón Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 4 => array:3 [ "nombre" => "BEATRIZ" "apellidos" => "PAZOS ARIAS" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "Iniciales" => "B." "apellidos" => "Pazos Arias" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 6 => array:3 [ "nombre" => "CARLOS" "apellidos" => "ROMERO REINOSO" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 7 => array:3 [ "Iniciales" => "C." "apellidos" => "Romero Reinoso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 8 => array:3 [ "nombre" => "ANGELES" "apellidos" => "PETEIRO CANCELO" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] 9 => array:3 [ "Iniciales" => "A." "apellidos" => "Peteiro Cancelo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "affe" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "NEFROLOGIA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Povisa, Vigo, Pontevedra, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Servicio de Oncología, Hospital Povisa, Vigo, Pontevedra, " "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 3 => array:3 [ "entidad" => "ANATOMÍA PATOLÓGICA, Hospital Povisa, Vigo, PONTEVEDRA, Spain, " "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] 4 => array:3 [ "entidad" => "Servicio de Anatomía Patológica, Hospital Povisa, Vigo, Pontevedra, " "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "affe" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nefropatía tras la administración de inhibidores de la angiogénesis" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor, </span></p><p class="elsevierStylePara">Angiogenesis has an important role in metastasis development. In recent years, the vascular endothelial growth factor (VEGF) has become one of the main objectives in treating tumour-induced angiogenesis.</p><p class="elsevierStylePara">Various studies have shown that the anti-VEGF monoclonal antibody, bevacizumab, can reduce angiogenesis and inhibit solid tumour growth.<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">Various secondary effects have been associated with bevacizumab use. Two of the most common effects are moderate proteinuria (up to 64% of cases) and hypertension. Nephrotic-range proteinuria only occurs in 1%-2% of bevacizumab-treated patients.<span class="elsevierStyleSup">2</span></p><p class="elsevierStylePara">We present the case of a 42-year-old man, diagnosed with grade II fibrosarcoma in the thigh and left-scapular region in November 1999. Tumour resection was indicated.</p><p class="elsevierStylePara">Three years later, he developed progressive pulmonary metastatic disease, which was treated with surgery and chemotherapy (MAID protocol: mesna, adriamycin, ifosfamide and dacarbazine).</p><p class="elsevierStylePara">In May 2004, he developed progressive pulmonary metastatic disease again and was treated with taxotere and gemcitabine, completing 6 cycles. He then completed 21 cycles of therapy with gemcitabine only.</p><p class="elsevierStylePara">In August 2008, he started gemcitabine and bevacizumab treatment, due to a disease relapse.</p><p class="elsevierStylePara">Following the second bevacizumab dosage, the patient was admitted due to headache, arterial hypertension (AHT) (BP: 190/100mm Hg) and general oedema. Upon admission, he had creatinine at 1.8mg/dl, nephrotic-range proteinuria and microhaematuria. Moderate normocytic/normochromic anaemia without schistocytes on the peripheral blood smear. Kidney ultrasound was normal. Immunological study only had low C3 levels. He had no previous history of AHT or kidney disease.</p><p class="elsevierStylePara">On the sixth day of his hospital stay, a renal biopsy was performed finding mesangiocapillary glomerulonephritis type II.</p><p class="elsevierStylePara">Gemcitabine and bevacizumab treatment was suspended and angiotensin II receptor antagonist (ARA-II) treatment started. Renal function improved, finally reaching creatinine levels of 1.1mg/dl; proteinuria decreased significantly and optimum blood pressure control was achieved.</p><p class="elsevierStylePara">Proteinuria in anti-VEGF-treated patients has been related to damage in the podocyte-endothelial-VEGF axis. VEGF production by podocytes is necessary for the glomerular endothelial to remain intact.<span class="elsevierStyleSup">2</span> VEGF is expressed in the podocytes and its receptors are found in the endothelial cells of the normal glomerular capillaries.<span class="elsevierStyleSup">3 </span>When VEGF binds to its receptor, it promotes an increase in the microvasculature’s permeability, cell migration and division, apoptosis inhibition and endothelial damage repair.<span class="elsevierStyleSup">4 </span></p><p class="elsevierStylePara">In animal studies, a defect in the VEGF expression causes glomerular diseases characterised by nephrotic-range proteinuria, endotheliosis and hyaline deposits, which are similar to the kidney damage found in pre-eclampsia patients.<span class="elsevierStyleSup">5 </span></p><p class="elsevierStylePara">We only found a few glomerulonephritis cases associated with anti-VEGF antibodies in the medical literature, and most were thrombotic microangiopathies. Bevacizumab-induced mesangiocapillary glomerulonephritis seems to be very rare. We believe that more cases will gradually appear due to the increased use of these antibodies in oncology in recent years.</p><p class="elsevierStylePara">Proteinuria which appears as a result of bevacizumab-induced glomerular damage seems to be reversible, at least partially, when this chemotherapy agent is suspended.</p><p class="elsevierStylePara">Our case, and other similar cases of patients with metastasis which develop bevacizumab-induced proteinuria had been treated with other, potentially nephrotoxic agents. Our patient also received high doses of gemcitabine over a long period of time. Little is still known about gemcitabine’s mechanism of action on kidney damage, although we know that it is dose-dependent. In most cases, it is associated with haemolytic uremic syndrome,<span class="elsevierStyleSup">6</span> although we have also found isolated cases associated with mesangiocapillary glomerulonephritis.<span class="elsevierStyleSup">7 </span></p><p class="elsevierStylePara">Given that a kidney biopsy was not performed before bevacizumab treatment, we are not able to confirm that gemcitabine was not responsible for the patient’s symptoms. However, given that the kidney damage was not evident until the start of anti-VEGF antibody treatment, we believe that the agent responsible for these symptoms was bevacizumab. It is possible that gemcitabine treatment produces initial renal damage, which may have been exacerbated by bevacizumab administration.</p><p class="elsevierStylePara">We recommend a strict control of the arterial pressure and kidney function in patients undergoing monoclonal antibody therapies.</p>" "pdfFichero" => "P1-E518-S2912-A10729-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "1.\u{A0}Rugo HS. Bevacizumab in the treatment of breast cancer: rationale and current data. The Oncologist 2004;9(Suppl 1):43-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15178815" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-36. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18337603" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Stokes M, Erazo M, D¿Agati V. Glomerular disease related to anti-VEGF therapy. Kidney Int 2008;74:1487-91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18547991" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.\u{A0}Zhu X, Wu S, Dahut WL, Parikh CR. Am J Kidney Dis 2007;49:186-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261421" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Nephrotic syndrome after bevacizumab: case report and literature review.\u{A0}George BA, Zhou XJ, Toto R. Am J Kidney Dis 2007;49:E23-E29. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261417" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.\u{A0}Saif MW, McGee PJ. J Pancreas 2005;6(4):369-74." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.\u{A0}Fracasso PM, Tan BR, Grieff JM, el al. Journal of the National Cancer Institute 1999;91(20):1779-80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10528031" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/main.assets" "Apartado" => array:4 [ "identificador" => "35437" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Brief Case Reports" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000002/v0_201502091641/X201325141105158X/v0_201502091641/en/P1-E518-S2912-A10729-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105158X?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 2 | 5 |
2024 October | 53 | 42 | 95 |
2024 September | 46 | 36 | 82 |
2024 August | 55 | 58 | 113 |
2024 July | 39 | 25 | 64 |
2024 June | 40 | 43 | 83 |
2024 May | 48 | 24 | 72 |
2024 April | 38 | 37 | 75 |
2024 March | 30 | 23 | 53 |
2024 February | 164 | 37 | 201 |
2024 January | 26 | 24 | 50 |
2023 December | 18 | 17 | 35 |
2023 November | 26 | 28 | 54 |
2023 October | 23 | 30 | 53 |
2023 September | 30 | 32 | 62 |
2023 August | 32 | 23 | 55 |
2023 July | 31 | 28 | 59 |
2023 June | 30 | 24 | 54 |
2023 May | 43 | 33 | 76 |
2023 April | 18 | 10 | 28 |
2023 March | 32 | 26 | 58 |
2023 February | 19 | 31 | 50 |
2023 January | 31 | 22 | 53 |
2022 December | 39 | 22 | 61 |
2022 November | 30 | 39 | 69 |
2022 October | 40 | 47 | 87 |
2022 September | 41 | 45 | 86 |
2022 August | 43 | 54 | 97 |
2022 July | 30 | 48 | 78 |
2022 June | 34 | 27 | 61 |
2022 May | 31 | 40 | 71 |
2022 April | 38 | 52 | 90 |
2022 March | 35 | 29 | 64 |
2022 February | 30 | 33 | 63 |
2022 January | 42 | 30 | 72 |
2021 December | 29 | 36 | 65 |
2021 November | 33 | 42 | 75 |
2021 October | 32 | 46 | 78 |
2021 September | 30 | 45 | 75 |
2021 August | 25 | 37 | 62 |
2021 July | 27 | 28 | 55 |
2021 June | 19 | 22 | 41 |
2021 May | 34 | 37 | 71 |
2021 April | 69 | 16 | 85 |
2021 March | 36 | 41 | 77 |
2021 February | 24 | 8 | 32 |
2021 January | 20 | 17 | 37 |
2020 December | 20 | 18 | 38 |
2020 November | 24 | 7 | 31 |
2020 October | 11 | 18 | 29 |
2020 September | 15 | 5 | 20 |
2020 August | 21 | 9 | 30 |
2020 July | 28 | 8 | 36 |
2020 June | 19 | 11 | 30 |
2020 May | 20 | 12 | 32 |
2020 April | 23 | 18 | 41 |
2020 March | 21 | 8 | 29 |
2020 February | 29 | 28 | 57 |
2020 January | 28 | 18 | 46 |
2019 December | 31 | 22 | 53 |
2019 November | 30 | 17 | 47 |
2019 October | 13 | 9 | 22 |
2019 September | 28 | 15 | 43 |
2019 August | 10 | 11 | 21 |
2019 July | 18 | 20 | 38 |
2019 June | 15 | 6 | 21 |
2019 May | 12 | 10 | 22 |
2019 April | 24 | 32 | 56 |
2019 March | 15 | 17 | 32 |
2019 February | 11 | 17 | 28 |
2019 January | 22 | 14 | 36 |
2018 December | 92 | 49 | 141 |
2018 November | 155 | 23 | 178 |
2018 October | 171 | 22 | 193 |
2018 September | 80 | 5 | 85 |
2018 August | 67 | 13 | 80 |
2018 July | 43 | 9 | 52 |
2018 June | 41 | 9 | 50 |
2018 May | 42 | 11 | 53 |
2018 April | 47 | 4 | 51 |
2018 March | 71 | 8 | 79 |
2018 February | 37 | 4 | 41 |
2018 January | 47 | 6 | 53 |
2017 December | 50 | 8 | 58 |
2017 November | 42 | 5 | 47 |
2017 October | 35 | 10 | 45 |
2017 September | 63 | 10 | 73 |
2017 August | 44 | 3 | 47 |
2017 July | 53 | 10 | 63 |
2017 June | 43 | 4 | 47 |
2017 May | 56 | 10 | 66 |
2017 April | 52 | 5 | 57 |
2017 March | 40 | 22 | 62 |
2017 February | 22 | 10 | 32 |
2017 January | 31 | 7 | 38 |
2016 December | 67 | 11 | 78 |
2016 November | 75 | 9 | 84 |
2016 October | 68 | 17 | 85 |
2016 September | 131 | 3 | 134 |
2016 August | 194 | 4 | 198 |
2016 July | 173 | 6 | 179 |
2016 June | 123 | 0 | 123 |
2016 May | 120 | 0 | 120 |
2016 April | 76 | 0 | 76 |
2016 March | 79 | 0 | 79 |
2016 February | 92 | 0 | 92 |
2016 January | 103 | 0 | 103 |
2015 December | 106 | 0 | 106 |
2015 November | 68 | 0 | 68 |
2015 October | 60 | 0 | 60 |
2015 September | 68 | 0 | 68 |
2015 August | 55 | 0 | 55 |
2015 July | 53 | 0 | 53 |
2015 June | 38 | 0 | 38 |
2015 May | 50 | 0 | 50 |
2015 April | 7 | 0 | 7 |